Advertisements

Protalix BioTherapeutics Inc. (DE) (PLX) Stock Quote

Detailed Quote for Protalix BioTherapeutics Inc. (DE) (PLX)
$ 1.12   0.07 (+6.67%) Volume: 3.07m 4:01 PM EST Feb 24, 2017
After Hours:  $ 1.14   0.02 (+1.79%) Volume: 16.65k 7:40 PM EST Feb 24, 2017
Today 5d 1m 3m 1y more
Last Price
1.12
Change $
0.07
Change %
6.67%
Tick
  
Bid
N/A
Bid Size
0
Ask
N/A
Ask Size
0
Open
1.04
High
1.13
Low
0.9999
Prev Close
1.05
Last Trade
02/24/17
Volume
3.07m
52 Wk Hi
1.48000001
52 Wk Low
0.25999999
Market Cap
138.63m
Ex-Div Date
N/A
Div Rate
N/A
Yield
N/A
Shares
123,777,137
EPS (TTM)
0.50
PE Ratio
2.20
Exchange
NYSE MKT
News and Media for Protalix BioTherapeutics Inc. (DE) (PLX)
Sector News | Topic News
News for Protalix BioTherapeutics Inc. (DE) (PLX)
Tue, Feb 21, 2017
5:17 PM Protalix BioTherapeutics: New Institutional Ownership Swells Ahead Of Major Catalysts - SeekingAlpha
Sat, Feb 18, 2017
10:28 AM InvestorsGuru.com 10 Filtered Mid-Day Market Movers Recap - Investors Guru
Tue, Feb 14, 2017
4:50 PM Protalix BioTherapeutics Announces Record Date for the 2017 Annual Meeting of Stockholders - GlobeNewswire
Mon, Feb 13, 2017
12:53 PM Midday Gainers / Losers - SeekingAlpha
11:26 AM Protalix continues up move, shares ahead 27% - SeekingAlpha
7:01 AM Protalix BioTherapeutics to Participate in the 13th Annual WORLDSymposium(TM) 2017 - GlobeNewswire
Sat, Feb 04, 2017
10:37 AM InvestorsGuru.com 11 Filtered Mid-Day Market Movers Recap - Investors Guru
Fri, Feb 03, 2017
9:46 AM M&A Activity Could Kick Start Biotech Industry's Recovery in 2017: Today's Report on Benitec and Protalix - Accesswire
Tue, Jan 31, 2017
12:31 PM Protalix BioTherapeutics Is Making Significant Progress And The Market Is Beginning To Notice - SeekingAlpha
Mon, Jan 09, 2017
6:00 AM Protalix BioTherapeutics Provides Review of 2016 and Strategic Outlook for 2017 - GlobeNewswire
Wed, Jan 04, 2017
7:21 PM Protalix BioTherapeutics Reports Encouraging Phase 2 CF Results; Its Future Is Brighter Than Ever - SeekingAlpha
Tue, Jan 03, 2017
8:32 AM Protalix Bio's CF candidate shows encouraging results in mid-stage study; shares up 5% premarket - SeekingAlpha
7:30 AM Protalix BioTherapeutics Announces Positive Interim Results from Phase II Clinical Trial of alidornase alfa (AIR DNase(TM)) for the Treatment of Cystic Fibrosis - GlobeNewswire
Wed, Dec 28, 2016
12:29 PM Protalix BioTherapeutics Receives $24M Order, Is Well Funded, And Has Significant Upside - SeekingAlpha
Tue, Dec 27, 2016
7:30 AM Protalix BioTherapeutics Receives Confirmation of Order for over $24 Million of alfataliglicerase to Treat Gaucher Patients in Brazil - GlobeNewswire
Thu, Dec 22, 2016
11:06 AM Enrollment completed in Protalix Bio's mid-stage study of AIR DNase in cystic fibrosis, top-line data expected in two weeks; shares up 5% - SeekingAlpha
7:30 AM Protalix BioTherapeutics Announces Last Patient Enrolled in the AIR DNase(TM) Phase II Clinical Trial for Cystic Fibrosis - GlobeNewswire
Thu, Dec 15, 2016
8:15 AM Blog Coverage Protalix Receives Letter Intending Purchase of Alfataliglicerase to Treat Gaucher Patients in Brazil - Accesswire
1:10 AM Protalix BioTherapeutics Receives Letter Detailing Intended Purchases of Approximately $24 Million of alfataliglicerase to Treat Gaucher Patients in Brazil - GlobeNewswire
Wed, Dec 14, 2016
8:03 AM Protalix nabs $24M order for alfataliglicerase from Brazil; shares ahead 17% premarket - SeekingAlpha
More News for PLX >>

Tags for Protalix BioTherapeutics Inc. (DE)

Research stocks or mutual funds related to Protalix BioTherapeutics Inc. (DE) by keywords or tags. Find companies that have a similar focus to PLX. The keywords below have been associated to PLX by either user submission or electronic means.

biotechnology company biotech research pharmaceuticals research pharmaceuticals international research patent market pharmaceutical market corporate communication generic pharmaceutical pharmaceutical investment pharma strategy biotechnology market pharmaceutical research and development annual report pharmaceutical manufacturing company dupont pharmaceuticals pharmaceutical advisory boards Biological Products pharma marketing pharmaceutical industry marketing pharmaceutical software pharma manufacturing pharma license pharmaceutical supply chain kv pharmaceutical company clinical research pharmaceutical cro pharmaceutical sales pharmaceutical distributors biotech corporation pharmaceutical development pharmaceutical sales rep pharmaceutical reports pharmaceutical magazine pharma product development pharmaceutical patent Drugs pharmaceutical industry news pharmaceutical manufacturing software corporate communications pharmaceutical conference pharmaceutical manufacturing pharmaceutical formulation pharma reports publicity contract pharmaceutical pharmaceutical consulting pharmaceutical industry news release pharmaceutical studies pharmaceutical strategy